Brief: Acer Therapeutics Receives Notice Of Allowance Of Key U.S. Patent Application Covering Acer-001 Formulation

MindMaze Therapeutics Holding SA

07/10/2021 13:52

Oct 7 (Reuters) - Acer Therapeutics Inc  ACER.O :
    * ACER THERAPEUTICS RECEIVES NOTICE OF ALLOWANCE OF KEY U.S.
PATENT APPLICATION COVERING ACER-001 FORMULATION
    * ACER THERAPEUTICS INC - ACER'S PATENT IS EXPECTED TO BE
ISSUED
IN Q4 OF 2021 AND EXPIRE IN 2036

Source text for Eikon:  ID:nGNX3nHG7h 
Further company coverage:  ACER.O 

 ((Reuters.Briefs@thomsonreuters.com;))